AimsBackground-Keratoconus is generally held to be an absolute contraindication for photorefractive keratectomy (PRK). Corneas with inferior steepening on corneal topography are widely thought to have subclinical keratoconus. We were not convinced that this is always the case, as there seems to be a group ofpatients with a stable inferior steepening pattern on topography who show no other characteristics of clinical keratoconus. We thus decided to offer PRK to some of these patients under strictly defined criteria. Method-Four myopic patients with a topography pattern of inferior steepening were submitted to PRK. They were selected on the basis ofbeing aged over 35, with a stable refraction, no slit-lamp signs of keratoconus, and a corrected vision of not less than 6/7 (0.9) with a spherical spectacle correction. They gave fully informed consent that this was an experimental procedure.
spectacle correction. They gave fully informed consent that this was an experimental procedure.
Results-The refractive results at 6 months after operation were within the range one would expect for PRK on corneas with a regular 'bow-tie' topography and similar level of myopia. No unusual problems were encountered. Conclusion-We feel that the corneal topography pattern of inferior steepening is not always a contraindication for PRK. The concept of a physiological 'displaced apex syndrome' is discussed and illustrated by corneal Corneal topography was performed pre-and postoperatively with the EyeSys corneal analysis system. Topography was performed in the normal way along the visual axis, and also with the patient looking upwards one or two rings on the videokeratoscope for patients who had inferior steepening.
Four patients with a corneal topography pattern of inferior steepening were submitted to PRK. They were chosen on the basis of the criteria shown in Table 1 .
The corneal epithelium was removed manually using a Beaver blade. Pilocarpine 1% or 2% and diclofenac (Voltarol) were instilled 20 minutes preoperatively. PRK was done in the normal manner, with the patients fixating on the fixation light within the laser. A 5 mm treatment zone was used for all the patients. Immediately after the procedure, diclofenac and chloramphenicol ointment were instilled. Chloramphenicol ointment were used four times daily for the first week and steroid drops only used if it was felt that regression was occurring -that is, with the Summit laser we would expect the refraction to still be hypermetropic at 6 weeks, so if the refraction was plano or minus at the 6 week check, then fluorometholone eyedrops were given, four times daily for 1 month, tailing off over 2-3 months. The only patient needing steroids was patient 3, who was given fluorometholone from weeks 6 to 12 postoperatively.
The patients' personal details and preoperative refractions are shown in Table 2 All four patients showed bilateral inferior steepening in their corneal topography with a Figure 3 show the same patient as in Figure 1 but with his topography performed with him looking upwards two rings while performing videokeratoscopy. Note the conversion from inferior steepening to the 'bow-tie' pattern of regular astigmatism.
Results
The refractive results are shown in Table 3 .
Patient 2 had some problems with night halos for a few weeks but seems to have adapted and now does not notice them at all. Patient 3 has night halos as he has very large pupils. (We only used a 5 mm beam size on these patients.) Patient 3 also has some loss of contrast sensitivity owing to subepithelial haze formation which is slowly clearing.
The topography of patient 1 after treatment of her right eye is shown in Figure 4 along with the untreated eye, which is enantiomorphic and almost exactly similar to the preoperative appearance of the right eye.
Discussion
We became interested in performing PRK on people with a 'keratoconic' pattern ofinferior corneal steepening from the following observations. Corneal topography unchanged I year later.
PRK in patients with a keratoconic topography picture. The concept of a physiological 'displaced apex syndrome' Figure 1 Neither do we know if keratoconus is one disease or merely the final common pathway of a number of genetic and/or environmental factors. However, if PRK does not lead to a progression of the disease, or any other abnormal reaction (such as an abnormal scarring reaction), then the distinction between the two groups may not matter in practice and what will matter more is the algorithm used by the lasering to correct the irregular comeal shape.
Three of our four patients have done very well following their PRK. The slight regression of the fourth patient has followed the pattern seen in other patients with regular corneal topography. Because of his night halos and slight regression, he could have a zone enlargement/retreatment with one of the more modern lasers when he is stable. None of the patients has shown any further changes suggestive of activation of an underlying keratoconic process. However, we clearly need to follow all these patients over a longer time period before assuming that they do not behave abnormally.
As the irregular astigmatism becomes more marked, then axial PRK, which imposes a regular spherical optical solution onto an irregular non-spherical cornea, becomes a more and more unsatisfactory solution to the optics of these eyes. The treatment of clinical keratoconus from mild to severe progresses from glasses to gas permeable contact lenses and finally to keratoplasty as the disease worsens and the cornea becomes more deformed. We would expect axial PRK or photorefractive astigmatic keratectomy (PARK) as it is presently available to work only in the group where glasses give satisfactory vision.
Gibralter and Trokel15 have made early moves to treat more severe irregular astigmatism by using overlapping circular zones. Two other approaches are:
(1) To treat the patient with PARK while he fixates non-axially. This presents formidable problems, not least that of getting a good nonaxial refraction/retinoscopy.
(2) Tying the corneal topography directly into the laser software to sculpt the corneal profile accordingly. We think that this latter approach will be the better long term solution and is looked upon by many as the 'Holy Grail' of corneal laser surgery.
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